[OS6-1-1] MEK阻害剤の至適投与時期検討を目的とした神経芽腫MRDモデルの確立
Minimal residual disease models to evaluate the optimal dose and timing of MEK inhibitor treatment for neuroblastoma
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.